CAMC Launches Lung Cancer Screening Program

  In an effort to catch lung cancer earlier and in more people, Charleston Area Medical Center (CAMC) has begun a lung cancer screening program. Lung cancer is the most prevalent type of cancer in West Virginia, according to the West Virginia Cancer Registry.

Screening includes a low-dose CT scan, a service covered by Medicare, and access to smoking cessation resources.

“It’s not as simple as just doing a CT scan,” CAMC public relations officer Dale Witte wrote in an email. Other components of the program include smoking cessation education, follow-up with a nurse navigator, and the submission of screening results to an American College of Radiology registry. The submission of screening data is a Medicare requirement for continued funding and for tracking the efficacy of the program.

The Centers for Medicare and Medicare Services approved payment for low-dose CT scans for lung cancer screening earlier this year. The screening costs $99 to those not covered by insurance.

Patients are required to have a doctor’s order for screening and may have to meet other criteria such as age and smoking history in order to qualify.

West Virginia has the second highest lung cancer rate in the country, according to 2012 data from the West Virginia Department for Health and Human Resources. Recent studies, including one from the National Cancer Institute in 2010, have found low-dose helical CT scans were 15-20 percent more effective than standard chest X-rays in detecting cancer early.

New Organization Aims to Improve Access to Clinical Cancer Trials in W.Va.

There’s a new nonprofit in West Virginia that wants to provide residents with greater access to cutting-edge cancer care. The West Virginia Cancer Clinical Trials Network officially launched today. The nonprofit is a growing collaboration of cancer physicians and healthcare organizations from across the state. The organization hopes to make more clinical cancer trials available to patients throughout West Virginia.

The National Cancer Institute describes clinical cancer trials as “research studies that involve people. They are the final step in a long process that begins with research in a lab.” 

Cancer clinical trials are designed to test new ways to:

  • Treat cancer
  • Find and diagnose cancer
  • Prevent cancer
  • Manage symptoms of cancer or side effects from its treatment

In a press conference, Director of the Mary Babb Randolph Cancer Center at West Virginia University, Scot Remick, M.D., explained that clinical trials are key to developing new methods to prevent, detect, and treat cancer. And he said West Virginians need to participate.
“This is a state that has year-in and year-out the highest cancer mortality rate in the country. Many tumor types are seen in increased incidents. And it’s unacceptable. And we know from a study that we did that about 20 percent of patients leave this state for cancer care,” Remick said. “Those patie don’t want to leave the state. They want to be closer to home; they want to be able to work; they want to be able to be near their families.”

Until now, clinical trials have only been available in a few regions of the state. The network now includes the Mary Babb Randlof Cancer Center in Morgantown, United Hospital Center in Bridgeport, Camden Clark Memorial Hospital in Parkersburg, Davis Memorial Hospital in Elkins, Berkeley Medical Center in Martinsburg, and St. Mary’s Medical Center in Huntington.  The network hopes to continue to include more physicians and medical facilities throughout the state.

Exit mobile version